U.S. Interventional Oncology Market (2025 - 2030) Size, Share & Trends Analysis Report By Technique (Ablation Therapies, Embolization Therapies), By Procedure (Tumor Ablation, Tumor Biopsy), By Application, By End Use, And Segment Forecasts

Table of Contents

Chapter 1. Methodology and Scope
                    1.1. Market Segmentation & Scope
                    1.2. Market Definitions
                        1.2.1. Technique Segment
                        1.2.2. Procedure Segment
                        1.2.3. Application Segment
                        1.2.4. End-use Segment
                    1.3. Information analysis
                        1.3.1. Market formulation & data visualization
                    1.4. Data validation & publishing
                    1.5. Information Procurement
                        1.5.1. Primary Research
                    1.6. Information or Data Analysis
                    1.7. Market Formulation & Validation
                    1.8. Market Model
                    1.9. Total Market: CAGR Calculation
                    1.10. Objectives
                        1.10.1. Objective 1
                        1.10.2. Objective 2
Chapter 2. Executive Summary
                    2.1. Market Outlook
                    2.2. Segment Snapshot
                    2.3. Competitive Insights Landscape
Chapter 3. U.S. Interventional Oncology Market Variables, Trends & Scope
                    3.1. Market Lineage Outlook
                        3.1.1. Parent market outlook
                        3.1.2. Related/ancillary market outlook.
                    3.2. Market Dynamics
                        3.2.1. Market driver analysis
                            3.2.1.1. Increasing prevalence of cancer
                            3.2.1.2. Increasing technological advancements in minimally invasive procedures
                            3.2.1.3. Growing geriatric population
                            3.2.1.4. Increasing investments in the field of interventional oncology
                        3.2.2. Market restraint analysis
                            3.2.2.1. High cost associated with interventional oncology
                            3.2.2.2. Requirement of highly skilled professionals
                    3.3. Interventional Oncology Market Analysis Tools
                        3.3.1. Industry Analysis - Porter’s
                        3.3.2. PESTEL Analysis
Chapter 4. U.S. Interventional Oncology Market: Technique Estimates & Trend Analysis
                    4.1. Segment Dashboard
                    4.2. U.S. Interventional Oncology Market Technique Movement Analysis
                    4.3. U.S. Interventional Oncology Market Size & Trend Analysis, by Technique, 2018 to 2030 (USD Million)
                    4.4. Ablation Therapies
                        4.4.1. Ablation Therapies market estimates and forecasts, 2018 to 2030 (USD Million)
                        4.4.2. Radiofrequency Ablation (RFA)
                            4.4.2.1. Radiofrequency Ablation (RFA) market estimates and forecasts, 2018 to 2030 (USD Million)
                        4.4.3. Microwave Ablation (MWA)
                            4.4.3.1. Microwave Ablation (MWA) market estimates and forecasts, 2018 to 2030 (USD Million)
                        4.4.4. Cryoablation
                            4.4.4.1. Cryoablation market estimates and forecasts, 2018 to 2030 (USD Million)
                        4.4.5. Laser Ablation
                            4.4.5.1. Laser Ablation market estimates and forecasts, 2018 to 2030 (USD Million)
                        4.4.6. Irreversible Electroporation (IRE)
                            4.4.6.1. Irreversible Electroporation (IRE) market estimates and forecasts, 2018 to 2030 (USD Million)
                    4.5. Embolization Therapies
                        4.5.1. Embolization Therapies market estimates and forecasts, 2018 to 2030 (USD Million)
                        4.5.2. Transarterial Chemoembolization (TACE)
                            4.5.2.1. Transarterial Chemoembolzation (TACE) market estimates and forecasts, 2018 to 2030 (USD Million)
                        4.5.3. Transarterial Radioembolization (TARE)
                            4.5.3.1. Transarterial Radioembolization (TARE) market estimates and forecasts, 2018 to 2030 (USD Million)
                    4.6. Biopsy Techniques
                        4.6.1. Biopsy Techniques market estimates and forecasts, 2018 to 2030 (USD Million)
                        4.6.2. Core Needle Biopsy
                            4.6.2.1. Core Needle Biopsy market estimates and forecasts, 2018 to 2030 (USD Million)
                        4.6.3. Fine Needle Aspiration (FNA)
                            4.6.3.1. Fine Needle Aspiration (FNA) market estimates and forecasts, 2018 to 2030 (USD Million)
                    4.7. Targeted Therapy Delivery Systems
                        4.7.1. Drug Delivery Systems market estimates and forecasts, 2018 to 2030 (USD Million)
                        4.7.2. Drug-Eluting Beads
                            4.7.2.1. Drug-Eluting Beads market estimates and forecasts, 2018 to 2030 (USD Million)
                        4.7.3. Radioembolization
                            4.7.3.1. Radioembolization market estimates and forecasts, 2018 to 2030 (USD Million)
                        4.7.4. Drug-Eluting Stents
                            4.7.4.1. Drug-Eluting Stents market estimates and forecasts, 2018 to 2030 (USD Million)
                        4.7.5. Injectable Hydrogels and Nanoparticles
                            4.7.5.1. Injectable Hydrogels and Nanoparticles market estimates and forecasts, 2018 to 2030 (USD Million)
                        4.7.6. Other Targeted Therapy Systems
                            4.7.6.1. Other Targeted Therapy Systems market estimates and forecasts, 2018 to 2030 (USD Million)
                    4.8. Image-Guided Procedures
                        4.8.1. Image-Guided Procedures market estimates and forecasts, 2018 to 2030 (USD Million)
                        4.8.2. Ultrasound Guidance
                            4.8.2.1. Ultrasound Guidance market estimates and forecasts, 2018 to 2030 (USD Million)
                        4.8.3. CT Scan Guidance
                            4.8.3.1. CT Scan Guidance market estimates and forecasts, 2018 to 2030 (USD Million)
                        4.8.4. MRI Guidance
                            4.8.4.1. MRI Guidance market estimates and forecasts, 2018 to 2030 (USD Million)
                        4.8.5. Fluoroscopy Guidance
                            4.8.5.1. Fluoroscopy Guidance market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 5. U.S. Interventional Oncology Market: Procedures Estimates & Trend Analysis
                    5.1. Segment Dashboard
                    5.2. U.S. Interventional Oncology Market Procedures Movement Analysis
                    5.3. U.S. Interventional Oncology Market Size & Trend Analysis, by Procedures, 2018 to 2030 (USD Million)
                    5.4. Tumor Ablation
                        5.4.1. Tumor Ablation market estimates and forecasts, 2018 to 2030 (USD Million)
                    5.5. Tumor Biopsy
                        5.5.1. Tumor Biopsy market estimates and forecasts, 2018 to 2030 (USD Million)
                    5.6. Vascular Interventions
                        5.6.1. Vascular Interventions market estimates and forecasts, 2018 to 2030 (USD Million)
                    5.7. Palliative Care
                        5.7.1. Palliative Care market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 6. U.S. Interventional Oncology Materials Market: Applications Estimates & Trend Analysis
                    6.1. Segment Dashboard
                    6.2. U.S. Interventional Oncology Market Applications Movement Analysis
                    6.3. U.S. Interventional Oncology Market Size & Trend Analysis, by Applications, 2018 to 2030 (USD Million)
                    6.4. Liver Cancer
                        6.4.1. Liver Cancer market estimates and forecasts, 2018 to 2030 (USD Million)
                    6.5. Lung Cancer
                        6.5.1. Lung Cancer market estimates and forecasts, 2018 to 2030 (USD Million)
                    6.6. Kidney Cancer
                        6.6.1. Kidney Cancer market estimates and forecasts, 2018 to 2030 (USD Million)
                    6.7. Prostate Cancer
                        6.7.1. Prostate Cancer market estimates and forecasts, 2018 to 2030 (USD Million)
                    6.8. Breast Cancer
                        6.8.1. Breast Cancer market estimates and forecasts, 2018 to 2030 (USD Million)
                    6.9. Other Cancer
                        6.9.1. Other Cancer market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 7. U.S. Interventional Oncology Market: End-use Estimates & Trend Analysis
                    7.1. Segment Dashboard
                    7.2. U.S. Interventional Oncology Market End Use Movement Analysis
                    7.3. U.S. Interventional Oncology Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
                    7.4. Hospitals
                        7.4.1. Hospitals market estimates and forecasts, 2018 to 2030 (USD Million)
                    7.5. Specialty Clinics
                        7.5.1. Specialty Clinics market estimates and forecasts, 2018 to 2030 (USD Million)
                    7.6. Others
                        7.6.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 8. Competitive Landscape
                    8.1. Company/Competition Categorization
                    8.2. Strategy Mapping
                    8.3. Company Market Position Analysis, 2024
                    8.4. Company Profiles/Listing
                        8.4.1. Medtronic
                            8.4.1.1. Company overview
                            8.4.1.2. Financial performance
                            8.4.1.3. Product benchmarking
                            8.4.1.4. Strategic initiatives
                        8.4.2. Boston Scientific Corporation
                            8.4.2.1. Company overview
                            8.4.2.2. Financial performance
                            8.4.2.3. Product benchmarking
                            8.4.2.4. Strategic initiatives
                        8.4.3. Johnson & Johnson (Ethicon)
                            8.4.3.1. Company overview
                            8.4.3.2. Financial performance
                            8.4.3.3. Product benchmarking
                            8.4.3.4. Strategic initiatives
                        8.4.4. Cook Medical
                            8.4.4.1. Company overview
                            8.4.4.2. Financial performance
                            8.4.4.3. Product benchmarking
                            8.4.4.4. Strategic initiatives
                        8.4.5. AngioDynamics Inc.
                            8.4.5.1. Company overview
                            8.4.5.2. Financial performance
                            8.4.5.3. Product benchmarking
                            8.4.5.4. Strategic initiatives
                        8.4.6. Stryker
                            8.4.6.1. Company overview
                            8.4.6.2. Financial performance
                            8.4.6.3. Product benchmarking
                            8.4.6.4. Strategic initiatives
                        8.4.7. Terumo Corporation
                            8.4.7.1. Company overview
                            8.4.7.2. Financial performance
                            8.4.7.3. Product benchmarking
                            8.4.7.4. Strategic initiatives
                        8.4.8. Siemens Healthineers (Varian)
                            8.4.8.1. Company overview
                            8.4.8.2. Financial performance
                            8.4.8.3. Product benchmarking
                            8.4.8.4. Strategic initiatives
                        8.4.9. Teleflex Incorporated
                            8.4.9.1. Company overview
                            8.4.9.2. Financial performance
                            8.4.9.3. Product benchmarking
                            8.4.9.4. Strategic initiatives
                        8.4.10. Profound Medical
                            8.4.10.1. Company overview
                            8.4.10.2. Financial performance
                            8.4.10.3. Product benchmarking
                            8.4.10.4. Strategic initiatives

List of Tables

Table 1 List of secondary sources
Table 2 List of abbreviations
Table 3 U.S. interventional oncology market by modality, 2018 - 2030 (USD Million)
Table 4 U.S. interventional oncology market by technology, 2018 - 2030 (USD Million)
Table 5 U.S interventional oncology market by mobility, 2018 - 2030 (USD Million)
Table 6 U.S interventional oncology market by end use, 2018 - 2030 (USD Million)
Table 7 Participant’s overview
Table 8 Financial performance
Table 9 Key companies undergoing expansions
Table 10 Key companies undergoing acquisitions
Table 11 Key companies undergoing collaborations
Table 12 Key companies launching new products
Table 13 Key companies undergoing partnerships
Table 14 Key companies undertaking other strategies

List of Figures

Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Market formulation & validation
Fig. 4 U.S. interventional oncology market: Market outlook
Fig. 5 U.S. interventional oncology market: Segment outlook
Fig. 6 U.S. interventional oncology market: Competitive landscape outlook
Fig. 7 Parent market outlook
Fig. 8 U.S. interventional oncology market driver impact
Fig. 9 U.S. interventional oncology market restraint impact
Fig. 10 U.S. interventional oncology market: Technique outlook and key takeaways
Fig. 11 U.S. interventional oncology market: Technique movement analysis
Fig. 12 Ablation therapies market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 13 Radiofrequency Ablation (RFA) market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 14 Microwave Ablation (MWA) market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 15 Cryoablation market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 16 Laser Ablation market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 17 Irreversible Electroporation (IRE) market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 18 Embolization therapies market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 19 Transarterial Chemoembolization (TACE) market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 20 Transarterial Radioembolization (TARE) market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 21 Biopsy rechniques market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 22 Core needle biopsy market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 23 Fine Needle Aspiration (FNA) market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 24 Targeted therapy delivery systems market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 25 Drug-eluting beads market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 26 Radioembolization market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 27 Drug-eluting stents market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 28 Injectable Hydrogels and Nanoparticles market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 29 Other targeted therapy systems market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 30 Image-guided procedures market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 31 ultrasound guidance market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 32 CT scan guidance market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 33 MRI guidance market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 34 Fluoroscopy Guidance market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 35 U.S. interventional oncology market: Procedures outlook and key takeaways
Fig. 36 U.S. interventional oncology market: Procedures movement analysis
Fig. 37 Tumor ablation market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 38 Tumor biopsy market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 39 Vascular interventions market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 40 Palliative care market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 41 U.S. interventional oncology market: Applications outlook and key takeaways
Fig. 42 U.S. interventional oncology market: Applications movement analysis
Fig. 43 Liver cancer market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 44 Lung cancer market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 45 Kidney cancer market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 46 Prostate cancer market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 47 Breast cancer market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 48 Other cancer market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 49 U.S. interventional oncology market: End-use outlook and key takeaways
Fig. 50 U.S. interventional oncology market: End-use movement analysis market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 51 Hospitals market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 52 Specialty clinics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 53 Others market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 54 Other market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 55 Heat map analysis
Fig. 56 Market participant categorization
Fig. 57 U.S. interventional oncology market share analysis, 2024
Fig. 58 Strategy framework